Clicky

Becton, Dickinson and Company(BDX)

Description: Becton, Dickinson and Company, a medical technology company, develops, manufactures, and sells medical devices, instrument systems, and reagents worldwide. The company's BD Medical segment produces medical devices that are used in various healthcare settings. This segment's products include needles, syringes, and intravenous catheters for medication delivery; prefilled IV flush syringes; syringes and pen needles used in treatment of diabetes; prefillable drug delivery systems; anesthesia needles and trays; sharps disposal containers; and closed-system transfer devices. Its BD Diagnostics segment provides products for the collection and transport of diagnostics specimens; and instrument systems and reagents to detect various infectious diseases, healthcare-associated infections, and cancers. This segment's products comprise integrated systems for specimen collection; safety-engineered blood collection products and systems; automated blood culturing systems; molecular testing systems; microorganism identification and drug susceptibility systems; liquid-based cytology systems; rapid diagnostic assays; microbiology laboratory automation; and plated media. The company's BD Biosciences segment offers research and clinical tools that facilitate the study of cells and their components. This segment's products include fluorescence-activated cell sorters and analyzers; monoclonal antibodies and kits for performing cell analysis; reagent systems for life science research; cell imaging systems; laboratory products for tissue culture and fluid handling; diagnostic assays; and cell culture media supplements for biopharmaceutical manufacturing. The company markets its products through independent distribution channels and sales representatives to healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry, and the general public. Becton, Dickinson and Company was founded in 1897 and is headquartered in Franklin Lakes, New Jersey.


Keywords: Medicine Biotechnology Cancer S&P 500 Biology Diabetes Infectious Diseases Medical Technology Medical Device Antibodies Monoclonal Antibodies Catheter Drug Delivery Medical Test Microbiology Syringe Anesthesia Healthcare Institutions Drug Delivery Systems Laboratory Products Treatment Of Diabetes Cell Culture Flow Cytometry Drug Delivery System Pharmaceutical Manufacturing Culture Media Biopharmaceutical Manufacturing Clinical Tools Reagent Systems Healthcare Setting Instrument Systems Transfer Devices

Home Page: www.bd.com

BDX Technical Analysis

1 Becton Drive
Franklin Lakes, NJ 07417-1880
United States
Phone: 201 847 6800


Officers

Name Title
Mr. Thomas E. Polen Jr. Pres, CEO & Chairman
Mr. Christopher DelOrefice Exec. VP & CFO
Mr. Samrat S. Khichi Esq. Exec. VP of Corp. Devel., Public Policy & Regulatory Affairs and Gen. Counsel
Mr. Thomas J. Spoerel Sr. VP, Controller & Chief Accounting Officer
Ms. Elizabeth McCombs Exec. VP & Chief Technology Officer
Dr. Joseph M. Smith F.A.C.C, M.D., Ph.D. Sr. VP, Chief Scientific Officer & Co-Chair of Scientific Advisory Board
Ms. Denise Fleming Exec. VP of Technology & Global Services and Chief Information Officer
Ms. Francesca M. DeMartino Sr. VP & Head of Investor Relations
Michelle Quinn Sr. VP and Chief Ethics & Compliance Officer
Troy Kirkpatrick VP of PR

Exchange: NYSE

Country: US

Currency: US Dollar ($)

Forward PE: 20.5761
Trailing PE: 46.9238
Price-to-Book MRQ: 2.8477
Price-to-Sales TTM: 3.762
IPO Date: 1987-01-01
Fiscal Year End: September
Full Time Employees: 77000
Back to stocks